Welcome to LookChem.com Sign In|Join Free

CAS

  • or

183293-82-5

Post Buying Request

183293-82-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

183293-82-5 Usage

Uses

Atherosclerosis therapy; treatment of lipoprotein disorders.

Check Digit Verification of cas no

The CAS Registry Mumber 183293-82-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,3,2,9 and 3 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 183293-82:
(8*1)+(7*8)+(6*3)+(5*2)+(4*9)+(3*3)+(2*8)+(1*2)=155
155 % 10 = 5
So 183293-82-5 is a valid CAS Registry Number.
InChI:InChI=1/C16H30O5/c1-15(2,13(17)18)9-5-7-11-21-12-8-6-10-16(3,4)14(19)20/h5-12H2,1-4H3,(H,17,18)(H,19,20)

183293-82-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-(5-carboxy-5-methylhexoxy)-2,2-dimethylhexanoic acid

1.2 Other means of identification

Product number -
Other names Gemcabene

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:183293-82-5 SDS

183293-82-5Relevant articles and documents

GEMCABENE, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR

-

Paragraph 0595-0596, (2018/11/21)

This present invention provides gemcabene pharmaceutically acceptable salts having a PSD90 of 35 μm to about 90 μm, methods for purifying crude gemcabene, pharmaceutically acceptable salts of purified gemcabene, pharmaceutical compositions of a gemcabene pharmaceutically acceptable salt and therapeutic and prophylactic methods useful for various conditions, including dyslipidemia.

Carnitine Conjugates As Dual Prodrugs, Methods Of Production And Uses Thereof

-

, (2009/01/24)

The present invention discloses novel dual prodrug compounds of formula (1), methods for their preparation and intermediates in their syntheses, formula (1): wherein A is a single bond, —O—, or —CH2—; m and n vary independently and are an integ

The preparation of carbon-14 and tritium radio-labeled PD-72953

Zhang, Yinsheng,Jian, Zhigang,Hong, Yang

, p. 602 - 604 (2008/02/05)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 183293-82-5